The chikungunya virus virus-like particle vaccine is well tolerated and shows high immunogenicity in both previous recipients ...

The chikungunya vaccination is recommended for those traveling to areas where there is a chikungunya outbreak.

Vaccine research has increasingly focused on virus-like particles (VLPs) due to their unique ability to mimic the structures of viruses without containing ...

The following is a summary of "Impact of HBsAg reduction via siRNA treatment on natural and vaccine (BRII-179)-induced ...

Shares of GeoVax Labs, Inc. (NASDAQ:GOVX – Get Free Report) have received an average recommendation of “Buy” from the seven ...

The number of influenza cases is surging across the United States, putting significant strain on many hospitals. We asked the ...

During a call between U.S. President Donald Trump and his Ukrainian counterpart, the U.S. leader apparently suggested ...

COVID and the 1918 flu pandemic gave us playbooks on how to prepare for the next pandemic. But we aren’t using it.

Measles virus particle, illustration. (Photo by KATERYNA KON/SCIENCE PHOTO ... meaning it was without continuous spread for at least 12 months. MMR vaccine is like a shield The CDC currently ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine approved in Europe for individuals as young as 12 years old. Vimkunya is a virus ...

The only Japanese player who had a quiet night was Cubs slugger Seiya Suzuki, who finished 0 for 4 at the plate. With a ...